Home
>
National Drug Code (NDC)
>
AVAPRO
AVAPRO - 0087-2771-31 - (IRBESARTAN)
Drug Information of AVAPRO
| Product NDC: | 0087-2771 |
| Proprietary Name: | AVAPRO |
| Non Proprietary Name: | IRBESARTAN |
| Active Ingredient(s): | 75 mg/1 & nbsp; IRBESARTAN |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of AVAPRO
| Product NDC: | 0087-2771 |
| Labeler Name: | Bristol-Myers Squibb Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020757 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19970930 |
Package Information of AVAPRO
| Package NDC: | 0087-2771-31 |
| Package Description: | 30 TABLET in 1 BOTTLE (0087-2771-31) |
NDC Information of AVAPRO
| NDC Code | 0087-2771-31 |
| Proprietary Name | AVAPRO |
| Package Description | 30 TABLET in 1 BOTTLE (0087-2771-31) |
| Product NDC | 0087-2771 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | IRBESARTAN |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19970930 |
| Marketing Category Name | NDA |
| Labeler Name | Bristol-Myers Squibb Company |
| Substance Name | IRBESARTAN |
| Strength Number | 75 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
